Search Tag: Beckman Coulter

Executive Health Management

New Access TSH (3rd IS) Assay Released with CE Mark for Use on the Beckman Coulter

2016 22 Jan

Beckman Coulter Diagnostics is pleased to announce obtaining CE Mark and the release of its new Access TSH (3rd IS) assay for use with the company’s Access Family of Immunoassay Systems. This new assay is the next generation of the Access HYPERsensitive hTSH and Access Fast hTSH assays for the quantitative determination of human thyroid stimulating... Read more

Executive Health Management

Beckman Coulter Expands Innovative Solutions for the Monitoring of HIV and AIDS in Africa

2015 20 Jul

Beckman Coulter Life Sciences has announced an expansion of its CARES (Cellular Accessible Retroviral Evaluation Systems) Initiative at the 2015 International AIDS Society (IAS) Conference, being held at the Vancouver Convention Centre from July 19-22, 2015 in Vancouver, Canada. CARES focuses on providing innovative solutions for the monitoring of HIV... Read more

Executive Health Management

Beckman Coulter Diagnostics Revolutionises Molecular Diagnostics

2015 28 Apr

LEAN Workflow and Reduced Sample Turn-around Times Beckman Coulter Diagnostics will be showcasing its revolutionary DxN VERIS Molecular Diagnostics System on Stand 253 at the 25th European Congress of Clinical Microbiology and Infectious Diseases, in Copenhagen, Denmark. The CE-marked system is now available with CE-marked assays for Human Cytomegalovirus... Read more

Executive Health Management

Bio-Rad Grants Beckman Coulter Exclusive Distribution Rights for Access HIV and Hepatitis C Assays

2015 21 Apr

HERCULES, CA and BREA, CA--(Marketwired - Apr 20, 2015) - Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a global provider of life science research and clinical diagnostic products and Beckman Coulter Diagnostics, a global leader in the clinical diagnostics industry, today announced that Bio-Rad is extending its agreement with Beckman Coulter... Read more

Lab Management

Automated AMH Given CE Mark Approval

2014 16 Sep

Beckman Coulter Diagnostics’ automated Anti-Müllerian Hormone test available to improve fertility assessment and treatment. Company brings innovation to women’s health with new assay to measure and predict ovarian response and reserve.Beckman Coulter Diagnostics has obtained CE Mark on its new automated Access anti-Müllerian hormone (AMH) assay. The... Read more

Executive Health Management

New Beckman Coulter Workcell Solution For In Vitro Diagnostic Use

2014 11 Apr

Scalable and customized hematology workcells help move labs forward by streamlining workflow with first pass results accuracyCapitalising on the advanced technologies behind Beckman Coulter Diagnostics’ DxH 800 and DxH Slidemaker Stainer cellular analysis systems, the company has released the new UniCel DxH connected Workcell solution for in vitro diagnostic... Read more

Executive Health Management

CE Mark Approval for Beckman Coulter’s Vitamin D Total Assay

2013 01 Nov

It was announced that Beckman Coulter has received the CE Mark approval for Access 25 (OH) Vitamin D Total assay for use on the Access 2 and UniCel DxI series of immunoassay system, an important addition to the company’s bone metabolism assay menu.Arnd Kaldowski, President of Beckman Coulter Diagnostics, is confident that the European CE Mark approval... Read more

Endorsed Companies